Home/Filings/4/0001193125-26-011837
4//SEC Filing

Pandite Arundathy N. 4

Accession 0001193125-26-011837

CIK 0001680367other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:45 PM ET

Size

6.8 KB

Accession

0001193125-26-011837

Insider Transaction Report

Form 4
Period: 2026-01-10
Pandite Arundathy N.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2026-01-10$4.75/sh6,851$32,542199,414 total
  • Award

    Common Stock

    [F1]
    2026-01-10+487,800487,800 total
    Exercise: $4.75Exp: 2036-01-10Common Stock (487,800 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 487,800 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2027, with the remaining three quarters vesting in equal monthly installments through January 10, 2030, subject to the Reporting Person's continued service to the Issuer.
Signature
/s/ Andrew R. Neill, Attorney-in-fact for Arundathy N. Pandite|2026-01-13

Documents

1 file

Issuer

Shattuck Labs, Inc.

CIK 0001680367

Entity typeother

Related Parties

1
  • filerCIK 0001827232

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:45 PM ET
Size
6.8 KB